Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXAIS: Xingnaojing for Acute Ischemic Stroke
NCT04813445Unknown
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- HM (Herbal Medicine), Combination Drug
- Countries
- 1
01
Overview
Randomised, open-label trial of Xingnaojing injection in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Change in National Institutes of Health Stroke Scale score at 10 days. Status: unknown.
02
Drugs
Xingnaojing injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04813445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04813445.